Latest multiple myeloma News

Monash Partners Comprehensive Cancer Consortium awards innovation grants to propel precision cancer treatment
Acquisition Of Gracell Completed
Sowing seeds for better cancer outcomes
Practice-changing study on bone marrow cancer therapy
AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases
Boost for life-changing medical research
New therapy target to shut down multiple myeloma’s ability to survive and thrive
Researchers chart contents of human bone marrow
HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO
Dan L Duncan Comprehensive Cancer Center to open cell therapy clinical trials at Harris Health
Support For Victorian Medical Research Powers On
Disrupting a core metabolic process in T cells may improve their therapeutic efficacy
New discovery: dual acting drug delivers blood cancer a lethal ‘one-two’ punch
Vital boost to blood cancer treatment
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement
World-first clinical trial for blood cancer underway in the Illawarra
Funding boost advances research on cancer vaccine
Highly Cited Researchers 2022
Big data used to identify existing drugs that could be repurposed for broader medical applications
Study sheds light on precancerous ‘clonal outgrowth’ in blood cells
New research shows rates of obesity-related cancers quadrupled in generation
New research identifies more effective weapon against blood cancers
Australians call for equitable access to new era in fighting cancer
“I’m very grateful” – Anne’s story of hope and ovarian cancer